Obsidian Therapeutics Appoints Rob Ross, M.D., to Board of Directors

Board expansion supports ongoing development of cytoDRiVE™ programs and external collaborations CAMBRIDGE, Mass., Sept. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Obsidian Therapeutics, Inc., a biotechnology company pioneering controllable ce... Biopharmaceuticals, Personnel Obsidian Therapeutics, gene therapies, cytoDRiVE
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news